American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …
Review included limited searches for new evidence and discussion of the search results …
Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis
SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …
Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical …
JA Frontera, JJ Lewin III, AA Rabinstein, IP Aisiku… - Neurocritical care, 2016 - Springer
Background The use of antithrombotic agents, including anticoagulants, antiplatelet agents,
and thrombolytics has increased over the last decade and is expected to continue to rise …
and thrombolytics has increased over the last decade and is expected to continue to rise …
Comparison of Hospital-at-Home models: a systematic review of reviews
MQ Leong, CW Lim, YF Lai - BMJ open, 2021 - bmjopen.bmj.com
Objectives To provide an overview of the safety and effectiveness of Hospital-at-Home
(HaH) according to programme type (early-supported discharge (ESD) vs admission …
(HaH) according to programme type (early-supported discharge (ESD) vs admission …
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Anticoagulants: a short history, their mechanism of action, pharmacology, and indications
M Heestermans, G Poenou, H Hamzeh-Cognasse… - Cells, 2022 - mdpi.com
Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent)
venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a …
venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a …
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee, MN Levine, RI Baker… - New England journal …, 2003 - Mass Medical Soc
Background Patients with cancer have a substantial risk of recurrent thrombosis despite the
use of oral anticoagulant therapy. We compared the efficacy of a low-molecular-weight …
use of oral anticoagulant therapy. We compared the efficacy of a low-molecular-weight …
Early discharge hospital at home
DC Gonçalves-Bradley, S Iliffe, HA Doll… - Cochrane Database …, 2017 - cochranelibrary.com
Background Early discharge hospital at home is a service that provides active treatment by
healthcare professionals in the patient's home for a condition that otherwise would require …
healthcare professionals in the patient's home for a condition that otherwise would require …